Scientists are excitedly investigating retatrutide, a novel treatment from Eli Lilly, as a possible step in weight reduction . Unlike many existing approaches, retatrutide is a dual -action agonist targeting simultaneously GLP-1 and GIP, chemicals that affect appetite and blood sugar regulation . E